# |
PMID |
Sentence |
1 |
11380611
|
Codon 61 mutations of N-ras seem to be involved in melanoma development on sun exposed sites.
|
2 |
11380611
|
In order to induce an immune response towards mutated N-ras proteins we performed a phase 1 feasibility study.
|
3 |
11380611
|
Ten melanoma patients were immunized intradermally 6 times with N-ras peptides (residue 49-73) with 4 codon 61 mutations using GM-CSF as adjuvant.
|
4 |
11380611
|
Codon 61 mutations of N-ras seem to be involved in melanoma development on sun exposed sites.
|
5 |
11380611
|
In order to induce an immune response towards mutated N-ras proteins we performed a phase 1 feasibility study.
|
6 |
11380611
|
Ten melanoma patients were immunized intradermally 6 times with N-ras peptides (residue 49-73) with 4 codon 61 mutations using GM-CSF as adjuvant.
|
7 |
11380611
|
Codon 61 mutations of N-ras seem to be involved in melanoma development on sun exposed sites.
|
8 |
11380611
|
In order to induce an immune response towards mutated N-ras proteins we performed a phase 1 feasibility study.
|
9 |
11380611
|
Ten melanoma patients were immunized intradermally 6 times with N-ras peptides (residue 49-73) with 4 codon 61 mutations using GM-CSF as adjuvant.
|
10 |
15837158
|
Likewise, the identification of activating mutations in the RAS signaling pathway, including the NRAS and BRAF genes, opens up new therapeutic options for RAS and RAF inhibitors.
|